Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Chief Executive Officer sold 2,562 shares at $1.63 ($4,176)
  3. 4 Open-market buy Chief Financial Officer bought 39,000 shares at $0.29 ($11,326)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Chief Operating Officer sold 4,368 shares at $3.19 ($13,942)
  9. 4 Open-market sale Chief Patient Supply Officer sold 4,368 shares at $3.19 ($13,942)
  10. 4 Open-market sale Chief Medical Officer sold 2,121 shares at $3.19 ($6,770)
  11. 4 Open-market sale Chief Executive Officer sold 11,096 shares at $3.19 ($35,416)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Chief Operating Officer sold 6,018 shares at an average $3.55 ($21,376)
  16. 4 Open-market sale Chief Patient Supply Officer sold 4,846 shares at an average $3.55 ($17,222)
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Chief Medical Officer sold 4,624 shares at an average $3.55 ($16,435)
  19. 4 Open-market sale Chief Executive Officer sold 17,408 shares at an average $3.55 ($61,877)
  20. 4 Derivatives Options or other derivatives

Page 6 of 18 · 351 filings